Toronto's Hospital for Sick Children is the most famous medical institution in Canada. In addition to being the largest pediatric centre in North America, it has earned an international reputation for clinical care and research that has influenced generations of health care practitioners across the country and around the world. In a very real sense, hospital staff have touched the lives of tens of thousands of children and their families. SickKids has an equally remarkable history - from its humble origins in rented houses in Victorian Toronto, the Hospital would flourish to become an influential paediatric institution, pioneering Pasteurization, the Iron Lung for Polio, Pablum, the Mustard Procedure for 'Blue Babies', and the discovery of the gene for Cystic Fibrosis. It would also be the site of two of most famous medical controversies in modern Canadian history -- the suspected murder of two dozen babies in the early 1980s and, more recently, the whistle-blowing controversy involving the research scientist, Nancy Olivieri. David Wright’s History of The Hospital for Sick Children chronicles this remarkable history of the SickKids, including its triumphs and tragedies, its discoveries and dead-ends. In doing so, Wright has crafted a compelling and accessible history of SickKids that anchors Toronto's children's hospital within the broader changes affecting Canadian society and medical practice over the last century.

SickKids Handbook of Pediatric Thrombosis and Hemostasis takes the reader through the entire field of paediatric thrombosis and hemostasis. This practical reference book will be a convenient, comprehensive, source of information and provides up-to-date, evidence-based guidance in the diagnosis and management of inherited and acquired bleeding disorders and thrombotic events of the venous, arterial, cardiac and central nervous systems that affect children, including the neonate. Written and reviewed by international experts in the field, SickKids Handbook of Pediatric Thrombosis and Hemostasis will guide health care professionals involved in the assessment and care of children with all types of bleeding and clotting disorders, including general and specialist pediatricians, in particular intensivists, neonatologists, cardiologists/cardiac surgeons, rheumatologists and nephrologists; hematologists/oncologists as well as nurses, nurse practitioners and pharmacists. Written in a user-friendly, algorithmic approach, the resource will serve students and trainees and assist teachers in developing practical lessons.

This updated and extended edition of the SickKids Handbook takes the reader through the entire field of pediatric thrombosis and hemostasis. An introductory section concisely explains the complex pathophysiology of thrombosis and hemostasis. The chapters that follow include practical, evidence-based information on the diagnosis and management of inherited and acquired bleeding disorders and thrombotic events of the venous, arterial, cardiac and central nervous systems that affect children. Special features include practical clinical algorithms and appendices that cite normal laboratory reference ranges, as well as recommended dosages of blood products and major hemostatic agents. A stand-alone chapter is dedicated to developmental hemostasis and bleeding in the neonate. A chapter on antithrombotic therapy in children gives succinct information on the old and new anticoagulants, antiplatelet drugs and thrombolytic agents. Written and reviewed by international experts in the field, this handbook is intended for health care professionals involved in the assessment and care of children with inherited and acquired bleeding and clotting disorders, including general and specialist pediatricians (in particular intensivists, neonatologists, cardiologists/cardiac surgeons, rheumatologists and nephrologists), hematologists/oncologists (pediatric and adult), as well as medical trainees, nurses, nurse practitioners and pharmacists.

An ALA Sydney Taylor Award Honoree A Junior Library Guild Selection Isabel has one rule: no dating. It’s easier— It’s safer— It’s better— —for the other person. She’s got issues. She’s got secrets. She’s got rheumatoid arthritis. But then she meets another sick kid. He’s got a chronic illness Isabel’s never heard of, something she can’t even pronounce. He understands what it means to be sick. He understands her more than her healthy friends. He understands her more than her own father who’s a doctor. He’s gorgeous, fun, and foul-mouthed. And totally into her. Isabel has one rule: no dating. It’s complicated— It’s dangerous— It’s never felt better— —to consider breaking that rule for him.

The Handbook for Supportive Care in Pediatric Oncology provides a practical approach to the clinical management of problems unique to childhood cancer and its therapy. It is expertly written by thirty-two pediatricians and allied health care professionals, and features 19 concise chapters organized alphabetically by organ system. Topics unique to this handbook include state-of-art information on the management of chemotherapy induced nausea, practical approaches to abdominal pain, and common psychiatric issues in pediatric oncology. An essential resource for all pediatric residents, fellows, practicing phyisicians, and nurse practitioners, this handbook is a comprehensive yet concise reference to the specific acute complications of pediatric cancer, hematologic emergencies, symptom management, and cancer therapy.

A timely work describing how localized hospital-based health technology assessment (HB-HTA) complements general, ‘arms-length’ HTA agency efforts, and what has been the collective global impact of HB-HTA across the globe. While HB-HTA has gained significant momentum over the past few years, expertise in the field, and information on the operation and organization of HB-HTA, has been scattered. This book serves to bring this information together to inform those who are currently working in the field of HTA at the hospital, regional, national or global level. In addition, this book is intended for decision-makers and policy-makers with a stake in determining the uptake and decommissioning of new and established technologies in the hospital setting. HTA has traditionally been performed at the National/Regional level by HTA Agencies, typically linked to governments. Yet hospitals are the main entry door for most health technologies (HTs). Hospital decision-makers must undertake multiple high stakes investment and disinvestment decisions annually for innovative HTs, usually without adequate information. Despite the existence of arms-length HTA Agencies, inadequate information is available to hospital decision-makers either because relevant HTA reports are not yet released at the time of entry of new technologies to the field, or because even when the report exists, the information contained is insufficient to clarify the contextualized informational needs of hospital decision makers. Therefore, there has recently been a rising trend toward hospital-based HTA units and programs. These units/programs complement the work of National/Regional HTA Agencies by providing the key and relevant evidence needed by hospital decision makers in their specific hospital context, and within required decision-making timelines. The emergence of HB-HTA is creating a comprehensive HTA ecosystem across health care levels, which creates better bridges for knowledge translation through relevance and timeliness.

The Reader contains educative and exciting chapters centred on the nursing profession and research areas of faculty members. The target readers are nursing students of all categories, nurse educators, administrators, clinicians, and researchers locally and internationally.